Skip to content
Medical Health Aged Care

Public Health peak welcomes new VicHealth CEO, Prof Anna Peeters

Public Health Association of Australia < 1 mins read

4 February 2025

 

The Public Health Association of Australia enthusiastically welcomes the appointment today of Professor Anna Peeters to the role of CEO of VicHealth.

VicHealth is a vital agency advancing the health of Victorians by focusing on health promotion, prevention, and public health. But it also plays an important national leadership role.

That is why the PHAA is so excited about the appointment of an outstanding leader in Professor Peeters as VicHealth’s new CEO.

“Professor Anna Peeters is leading expert in a range of areas of public and preventive health, particularly in obesity, and is a policy and research leader,” PHAA CEO, Adjunct Professor Terry Slevin said.

“She is evidence-driven, strategic, committed, and enormously highly regarded in the field.

“We very much look forward to working with Professor Peeters in her new role.”

 

 

For further information/comment:

Paris Lord (he/him), PHAA Communications & Media Manager, 0478 587 917, [email protected] 

 

 

 

 

 

 

About the Public Health Association of Australia

We’re Australia's peak body for public health and advocate for the health and wellbeing of everyone. We strive to help prevent – rather than cure – illness and disease. We represent around 2,000 individual members from more than 40 professional groups interested in the promotion of public health. We have branches in every State and Territory. Learn more at phaa.net.au


Contact details:

Paris Lord (he/him), PHAA Communications & Media Manager, 0478 587 917, [email protected] 

More from this category

  • Medical Health Aged Care
  • 18/12/2025
  • 22:11
BeOne Medicines Ltd.

BeOne Medicines Granted U.S. FDA Fast Track Designation for BGB-B2033 as Treatment for Hepatocellular Carcinoma

BGB-B2033 is a bispecific antibody directed at GPC3 and 4-1BB; key targets in the most common liver cancer FDA Fast Track Designation reflects the…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 19:11
Takeda Pharmaceutical Company Limited

Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment

Pivotal Phase 3 studies of once-daily oral zasocitinib met all primary and ranked secondary endpoints in patients with moderate-to-severe plaque psoriasis More than half…

  • Contains:
  • Medical Health Aged Care
  • 18/12/2025
  • 12:24
La Trobe University

Cell death discovery could aid cancer treatments

LaTrobe researchers have made a groundbreaking discovery about the way dying cells are cleared from our bodies, which could have important impacts on recovery from diseases including cancer infection and inflammatory diseases. Traditionally, it was believed dying cells were broken into smaller pieces by the cell’s own internal machinery, enabling the pieces to be more easily removed from the body. However the study, led by scientists at the La Trobe Institute for Molecular Science and Research Centre for Extracellular Vesicles found that the process of dying cell fragmentation is actually assisted by neighbouring cells. Published in Science Advances, the study…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.